{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:52:15Z","timestamp":1787068335015,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13052-017-0356-x","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T21:24:18Z","timestamp":1492723458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse"],"prefix":"10.1186","volume":"43","author":[{"given":"Andrea","family":"Pasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Ghio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Massella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Molino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Trivelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Maringhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Materassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Murer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pennesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,21]]},"reference":[{"issue":"9384","key":"356_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629\u201339.","journal-title":"Lancet"},{"key":"356_CR2","doi-asserted-by":"publisher","unstructured":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978;13(2):159\u201365.","DOI":"10.1038\/ki.1978.23"},{"issue":"10","key":"356_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2215\/CJN.05950809","volume":"4","author":"P Niaudet","year":"2009","unstructured":"Niaudet P. Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome. Clin J Am Soc Nephrol. 2009;4(10):1547\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"356_CR4","unstructured":"KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Kidney Int Suppl. 2012;(2):139\u2013274."},{"issue":"10","key":"356_CR5","first-page":"993","volume":"41","author":"P Hari","year":"2004","unstructured":"Hari P, Bagga A, Mantan M. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr. 2004;41(10):993\u20131000.","journal-title":"Indian Pediatr"},{"issue":"11","key":"356_CR6","first-page":"1405","volume":"23","author":"K Tsuzuki","year":"1981","unstructured":"Tsuzuki K, Tanabe M, Satoh C, et al. Betamethasone \u201cpulse\u201d therapy for children with idiopathic nephrotic syndrome -especially for fresh cases (author transl). Nihon Jinzo Gakkai Shi. 1981;23(11):1405\u201313.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"356_CR7","doi-asserted-by":"publisher","unstructured":"McLean TLK RH, Rasoulpour M. Intravenous methylprednisolone treatment of steroid responsive nephrotic syndrome. Pediat Res. 1980;14(8):1006.","DOI":"10.1203\/00006450-198008000-00196"},{"issue":"4","key":"356_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s004670050308","volume":"11","author":"M Broyer","year":"1997","unstructured":"Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol. 1997;11(4):418\u201322.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"356_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie. Eur J Pediatr. 1993;152(4):357\u201361.","journal-title":"Eur J Pediatr"},{"key":"356_CR10","volume-title":"Protocole national de disgnostic et de soins pour une maladie rare","author":"Syndrome N\u00e9phrotique Idiopathique de l\u2019Enfant","year":"2008","unstructured":"Syndrome N\u00e9phrotique Idiopathique de l\u2019Enfant. Protocole national de disgnostic et de soins pour une maladie rare. France: Haute Autorit\u00e9 de Sant\u00e9; 2008."},{"issue":"5","key":"356_CR11","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00467-008-1089-2","volume":"24","author":"J Feber","year":"2009","unstructured":"Feber J, Al-Matrafi J, Farhadi E, Vaillancourt R, Wolfish N. Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent? Pediatr Nephrol. 2009;24(5):1027\u201331.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"356_CR12","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00467-011-1961-3","volume":"26","author":"SA Saadeh","year":"2011","unstructured":"Saadeh SA, Baracco R, Jain A, Kapur G, Mattoo TK, Valentini RP. Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatr Nephrol. 2011;26(12):2167\u201371.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"356_CR13","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00467-011-1993-8","volume":"26","author":"O Mehls","year":"2011","unstructured":"Mehls O, Hoyer PF. Dosing of glucocorticosteroids in nephrotic syndrome. Pediatr Nephrol. 2011;26(12):2095\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"356_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s004670050344","volume":"11","author":"BK Ekka","year":"1997","unstructured":"Ekka BK, Bagga A, Srivastava RN. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol. 1997;11(5):597\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"356_CR15","first-page":"386","volume":"15","author":"X Li","year":"1994","unstructured":"Li X, Li Z, Cheng Z. Treatment of children with simple nephrotic syndrom using prednison once per day. Acta Academiae Medicinae Hubei. 1994;15(4):386\u20138.","journal-title":"Acta Academiae Medicinae Hubei"},{"key":"356_CR16","first-page":"Cd001533","volume":"3","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2015;3:Cd001533.","journal-title":"Cochrane Database Syst Rev"},{"key":"356_CR17","doi-asserted-by":"crossref","unstructured":"Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J Pediatr. 1979;95(2): 239\u201343","DOI":"10.1016\/S0022-3476(79)80658-7"},{"key":"356_CR18","volume":"4","author":"EM Hodson","year":"2000","unstructured":"Hodson EM, Knight JF, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2000;4, CD001533.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"356_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","volume":"24","author":"N Teeninga","year":"2013","unstructured":"Teeninga N, Kist-van Holthe JE, van Rijswijk N, et al. Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol. 2013;24(1):149\u201359.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"356_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, et al. Extending initial prednisolone treatment in a randomized control trial from 3 to 6\u00a0months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2015;87(1):217\u201324.","journal-title":"Kidney Int"},{"issue":"1","key":"356_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, et al. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int. 2015;87(1):225\u201332.","journal-title":"Kidney Int"},{"issue":"1","key":"356_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2014.354","volume":"87","author":"PF Hoyer","year":"2015","unstructured":"Hoyer PF. New lessons from randomized trials in steroid-sensitive nephrotic syndrome: clear evidence against long steroid therapy. Kidney Int. 2015;87(1):17\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"356_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00467-014-2903-7","volume":"30","author":"A Pasini","year":"2015","unstructured":"Pasini A, Aceto G, Ammenti A, et al. Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol. 2015;30(1):91\u2013101.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"356_CR24","first-page":"203","volume":"45","author":"A Bagga","year":"2008","unstructured":"Bagga A, Ali U, Banerjee S, et al. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2008;45(3):203\u201314.","journal-title":"Indian Pediatr"},{"issue":"2","key":"356_CR25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1542\/peds.2008-1559","volume":"124","author":"DS Gipson","year":"2009","unstructured":"Gipson DS, Massengill SF, Yao L, et al. Management of childhood onset nephrotic syndrome. Pediatrics. 2009;124(2):747\u201357.","journal-title":"Pediatrics"},{"issue":"8","key":"356_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s12098-012-0776-y","volume":"79","author":"A Sinha","year":"2012","unstructured":"Sinha A, Bagga A. Nephrotic syndrome. Indian J Pediatr. 2012;79(8):1045\u201355.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"356_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ki.1994.33","volume":"45","author":"MH Humphreys","year":"1994","unstructured":"Humphreys MH. Mechanisms and management of nephrotic edema. Kidney Int. 1994;45(1):266\u201381.","journal-title":"Kidney Int"},{"issue":"5","key":"356_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00467-014-2763-1","volume":"29","author":"D Bockenhauer","year":"2014","unstructured":"Bockenhauer D. Draining the edema: a new role for aquaretics? Pediatr Nephrol. 2014;29(5):767\u20139.","journal-title":"Pediatr Nephrol"},{"key":"356_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","volume":"31","author":"J McCaffrey","year":"2016","unstructured":"McCaffrey J, Lennon R, Webb NJA. The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol. 2016;31:1383\u2013402.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"356_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study. Clin J Am Soc Nephrol. 2009;4(5):907\u201313.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"356_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000168654","volume":"13","author":"JA Joles","year":"1993","unstructured":"Joles JA, Rabelink TJ, Braam B, Koomans HA. Plasma volume regulation: defences against edema formation (with special emphasis on hypoproteinemia). Am J Nephrol. 1993;13(5):399\u2013412.","journal-title":"Am J Nephrol"},{"key":"356_CR32","doi-asserted-by":"crossref","unstructured":"Minimal change nephrotic syndrome in children: deaths during the first 5 to 15\u00a0years\u2019 observation. Report of the International Study of Kidney Disease in Children. Pediatrics. 1984;73(4): 497\u2013501.","DOI":"10.1542\/peds.73.4.497"},{"issue":"1","key":"356_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00431-009-0989-x","volume":"169","author":"N Uncu","year":"2010","unstructured":"Uncu N, B\u00fclb\u00fcl M, Yildiz N, et al. Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study. Eur J Pediatr. 2010;169(1):73\u20136.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"356_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00006454-199603000-00012","volume":"15","author":"S Gulati","year":"1996","unstructured":"Gulati S, Kher V, Arora P, Gupta S, Kale S. Urinary tract infection in nephrotic syndrome. Pediatr Infect Dis J. 1996;15(3):237\u201340.","journal-title":"Pediatr Infect Dis J"},{"issue":"1\u20132","key":"356_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1440-1754.2004.00285.x","volume":"40","author":"RK Alwadhi","year":"2004","unstructured":"Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health. 2004;40(1\u20132):28\u201332.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"356_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/infdis\/157.2.309","volume":"157","author":"G Nyerges","year":"1988","unstructured":"Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis. 1988;157(2):309\u201313.","journal-title":"J Infect Dis"},{"key":"356_CR37","first-page":"Cd003964","volume":"4","author":"HM Wu","year":"2012","unstructured":"Wu HM, Tang JL, Cao L, Sha ZH, Li Y. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev. 2012;4:Cd003964.","journal-title":"Cochrane Database Syst Rev"},{"key":"356_CR38","first-page":"Cd003427","volume":"9","author":"C Hirst","year":"2012","unstructured":"Hirst C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev. 2012;9:Cd003427.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"356_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","volume":"34","author":"P McIntyre","year":"1998","unstructured":"McIntyre P, Craig JC. Prevention of serious bacterial infection in children with nephrotic syndrome. J Paediatr Child Health. 1998;34(4):314\u20137.","journal-title":"J Paediatr Child Health"},{"issue":"2 Pt 1","key":"356_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1542\/peds.106.2.367","volume":"106","author":"GD Overturf","year":"2000","unstructured":"Overturf GD. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 2000;106(2 Pt 1):367\u201376.","journal-title":"Pediatrics"},{"issue":"4","key":"356_CR41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004670050764","volume":"14","author":"SL Goldstein","year":"2000","unstructured":"Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol. 2000;14(4):305\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"356_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1067\/mpd.2003.37","volume":"142","author":"SL Furth","year":"2003","unstructured":"Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA. Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. J Pediatr. 2003;142(2):145\u20138.","journal-title":"J Pediatr"},{"issue":"3","key":"356_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00467-001-0789-7","volume":"17","author":"H Alpay","year":"2002","unstructured":"Alpay H, Yildiz N, Onar A, Temizer H, Ozcay S. Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17(3):181\u20133.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"356_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/000992280204100110","volume":"41","author":"A Shroff","year":"2002","unstructured":"Shroff A, Frank R, Vergara M, Gauthier B, Trachtman H. Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices. Clin Pediatr (Phila). 2002;41(1):47\u20139.","journal-title":"Clin Pediatr (Phila)"},{"issue":"7","key":"356_CR45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","volume":"23","author":"T Ulinski","year":"2008","unstructured":"Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatr Nephrol. 2008;23(7):1107\u201313.","journal-title":"Pediatr Nephrol"},{"issue":"17\u201318","key":"356_CR46","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.vaccine.2003.11.038","volume":"22","author":"D Bogaert","year":"2004","unstructured":"Bogaert D, Hermans PW, Adrian PV, Rumke HC, de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine. 2004;22(17\u201318):2209\u201320.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"356_CR47","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S0264-410X(99)00113-9","volume":"17","author":"DS Fedson","year":"1999","unstructured":"Fedson DS. The clinical effectiveness of pneumococcal vaccination: a brief review. Vaccine. 1999;17 Suppl 1:S85\u201390.","journal-title":"Vaccine"},{"issue":"1","key":"356_CR48","first-page":"1","volume":"31","author":"K Tinaztepe","year":"1989","unstructured":"Tinaztepe K, Buyan N, Tinaztepe B, Akk\u00f6k N. The association of nephrotic syndrome and renal vein thrombosis: a clinicopathological analysis of eight pediatric patients. Turk J Pediatr. 1989;31(1):1\u201318.","journal-title":"Turk J Pediatr"},{"issue":"1\u20132","key":"356_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s004679900253","volume":"15","author":"MI Lilova","year":"2000","unstructured":"Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974\u20131996). Pediatr Nephrol. 2000;15(1\u20132):74\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"356_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/BF00863459","volume":"10","author":"M Andrew","year":"1996","unstructured":"Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol. 1996;10(1):88\u201399.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"356_CR51","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7(3):513\u201320.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"356_CR52","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10157-013-0917-2","volume":"18","author":"D Suri","year":"2014","unstructured":"Suri D, Ahluwalia J, Saxena AK, et al. Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol. 2014;18(5):803\u201313.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"356_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05329.x","volume":"129","author":"C Dame","year":"2005","unstructured":"Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol. 2005;129(2):165\u201377.","journal-title":"Br J Haematol"},{"issue":"8","key":"356_CR54","first-page":"1647","volume":"7","author":"A Mittal","year":"2013","unstructured":"Mittal A, Aggarwal KC, Saluja S, Aggarwal A, Sureka B. Platelet functions and coagulation changes in Indian children with nephrotic syndrome. J Clin Diagn Res. 2013;7(8):1647\u201350.","journal-title":"J Clin Diagn Res"},{"key":"356_CR55","first-page":"487","volume":"16","author":"G Remuzzi","year":"1979","unstructured":"Remuzzi G, Marchesi D, Mecca G, de Gaetano G, Silver M. Platelet hypersensitivity in the nephrotic syndrome. Proc Eur Dial Transplant Assoc. 1979;16:487\u201394.","journal-title":"Proc Eur Dial Transplant Assoc"},{"issue":"6","key":"356_CR56","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0049-3848(81)90171-7","volume":"23","author":"E Walter","year":"1981","unstructured":"Walter E, Deppermann D, Andrassy K, Koderisch J. Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res. 1981;23(6):473\u20139.","journal-title":"Thromb Res"},{"issue":"1","key":"356_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2009.01.070","volume":"155","author":"BA Kerlin","year":"2009","unstructured":"Kerlin BA, Blatt NB, Fuh B, et al. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr. 2009;155(1):105\u201310. 10.e1.","journal-title":"J Pediatr"},{"issue":"8","key":"356_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00467-002-0865-7","volume":"17","author":"M Tkaczyk","year":"2002","unstructured":"Tkaczyk M, Baj Z. Surface markers of platelet function in idiopathic nephrotic syndrome in children. Pediatr Nephrol. 2002;17(8):673\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 1","key":"356_CR59","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0049-3848(08)70020-3","volume":"122","author":"FD George","year":"2008","unstructured":"George FD. Microparticles in vascular diseases. Thromb Res. 2008;122 Suppl 1:S55\u20139.","journal-title":"Thromb Res"},{"issue":"3 Suppl","key":"356_CR60","doi-asserted-by":"publisher","first-page":"645S","DOI":"10.1378\/chest.126.3_suppl.645S","volume":"126","author":"P Monagle","year":"2004","unstructured":"Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):645S\u201387S.","journal-title":"Chest"},{"issue":"2 Suppl","key":"356_CR61","doi-asserted-by":"publisher","first-page":"e737S","DOI":"10.1378\/chest.11-2308","volume":"141","author":"P Monagle","year":"2012","unstructured":"Monagle P, Chan AK, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e737S\u2013801S.","journal-title":"Chest"},{"key":"356_CR62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/asheducation.V2012.1.439.3798661","volume":"2012","author":"AK Chan","year":"2012","unstructured":"Chan AK, Monagle P. Updates in thrombosis in pediatrics: where are we after 20\u00a0years? Hematology Am Soc Hematol Educ Program. 2012;2012:439\u201343.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"356_CR63","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40272-015-0120-x","volume":"17","author":"C Law","year":"2015","unstructured":"Law C, Raffini L. A guide to the use of anticoagulant drugs in children. Paediatr Drugs. 2015;17(2):105\u201314.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"356_CR64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4292\/wjgpt.v4.i3.39","volume":"4","author":"M Guslandi","year":"2013","unstructured":"Guslandi M. Steroid ulcers: Any news? World J Gastrointest Pharmacol Ther. 2013;4(3):39\u201340.","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"19","key":"356_CR65","first-page":"A5540","volume":"157","author":"TP Dorlo","year":"2013","unstructured":"Dorlo TP, Jager NG, Beijnen JH, Schellens JH. Concomitant use of proton pump inhibitors and systemic corticosteroids. Ned Tijdschr Geneeskd. 2013;157(19):A5540.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"4","key":"356_CR66","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/pds.2350","volume":"21","author":"JC Munson","year":"2012","unstructured":"Munson JC, Wahl PM, Daniel G, Kimmel SE, Hennessy S. Factors associated with the initiation of proton pump inhibitors in corticosteroid users. Pharmacoepidemiol Drug Saf. 2012;21(4):366\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"356_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein RS. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med. 2011;365(1):62\u201370.","journal-title":"N Engl J Med"},{"issue":"8","key":"356_CR68","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/ndt\/gfh809","volume":"20","author":"S Gulati","year":"2005","unstructured":"Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant. 2005;20(8):1598\u2013603.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"356_CR69","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/ndt\/gft090","volume":"28","author":"MP Gruppen","year":"2013","unstructured":"Gruppen MP, Davin JC, Oosterveld MJ, et al. Prevention of steroid-induced low bone mineral density in children with renal diseases: a systematic review. Nephrol Dial Transplant. 2013;28(8):2099\u2013106.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"356_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s004670050568","volume":"13","author":"U Querfeld","year":"1999","unstructured":"Querfeld U. Should hyperlipidemia in children with the nephrotic syndrome be treated? Pediatr Nephrol. 1999;13(1):77\u201384.","journal-title":"Pediatr Nephrol"},{"key":"356_CR71","volume":"12","author":"X Kong","year":"2013","unstructured":"Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L. Lipid-lowering agents for nephrotic syndrome. Cochrane Database Syst Rev. 2013;12, CD005425.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"356_CR72","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-009-1137-6","volume":"24","author":"P Cochat","year":"2009","unstructured":"Cochat P, Fargue S, Mestrallet G, et al. Disease recurrence in paediatric renal transplantation. Pediatr Nephrol. 2009;24(11):2097\u2013108.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"356_CR73","first-page":"35","volume":"46","author":"A Gulati","year":"2009","unstructured":"Gulati A, Bagga A, Gulati S, Mehta KP, Vijayakumar M. Management of steroid resistant nephrotic syndrome. Indian Pediatr. 2009;46(1):35\u201347.","journal-title":"Indian Pediatr"},{"key":"356_CR74","doi-asserted-by":"publisher","unstructured":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr. 1981;98(4):561\u20134.","DOI":"10.1016\/S0022-3476(81)80760-3"},{"key":"356_CR75","doi-asserted-by":"publisher","unstructured":"KDIGO Clinical Practice Guideline Chapter 4: Steroid-resistant nephrotic syndrome in children. Kidney Int Suppl. 2012;2(2):172\u20136.","DOI":"10.1038\/kisup.2012.17"},{"key":"356_CR76","unstructured":"Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet. 1974;2(7878):423\u20137."},{"issue":"4","key":"356_CR77","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015;10(4):592\u2013600.","journal-title":"Clin J Am Soc Nephrol"},{"key":"356_CR78","first-page":"226","volume":"5","author":"A Bierzynska","year":"2014","unstructured":"Bierzynska A, Soderquest K, Koziell A. Genes and podocytes - new insights into mechanisms of podocytopathy. Front Endocrinol (Lausanne). 2014;5:226.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"356_CR79","doi-asserted-by":"publisher","unstructured":"KDIGO Clinical Practice Guideline. Chapter 3: Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl. 2012;2(2):163\u201371.","DOI":"10.1038\/kisup.2012.16"},{"issue":"2","key":"356_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00467-005-2084-5","volume":"21","author":"BR Nammalwar","year":"2006","unstructured":"Nammalwar BR, Vijayakumar M, Prahlad N. Experience of renal biopsy in children with nephrotic syndrome. Pediatr Nephrol. 2006;21(2):286\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"356_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000167563","volume":"8","author":"HL Corwin","year":"1988","unstructured":"Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol. 1988;8(2):85\u20139.","journal-title":"Am J Nephrol"},{"key":"356_CR82","doi-asserted-by":"publisher","unstructured":"KDIGO Clinical Practice Guideline. Chapter 2: General principles in the management of glomerular disease. Kidney Int Suppl. 2012;2(2):156\u201362.","DOI":"10.1038\/kisup.2012.15"},{"key":"356_CR83","doi-asserted-by":"publisher","unstructured":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981;20(6): 765\u201371.","DOI":"10.1038\/ki.1981.209"},{"issue":"12","key":"356_CR84","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire. UK Pediatr Nephrol. 2001;16(12):1040\u20134.","journal-title":"UK Pediatr Nephrol"},{"issue":"6","key":"356_CR85","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00467-002-0840-3","volume":"17","author":"S Gulati","year":"2002","unstructured":"Gulati S, Sharma AP, Sharma RK, Gupta A, Gupta RK. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications? Pediatr Nephrol. 2002;17(6):404\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"356_CR86","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s004670100023","volume":"16","author":"S Gulati","year":"2001","unstructured":"Gulati S, Sural S, Sharma RK, Gupta A, Gupta RK. Spectrum of adolescent-onset nephrotic syndrome in Indian children. Pediatr Nephrol. 2001;16(12):1045\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"356_CR87","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s004670050414","volume":"12","author":"N Baqi","year":"1998","unstructured":"Baqi N, Singh A, Balachandra S, et al. The paucity of minimal change disease in adolescents with primary nephrotic syndrome. Pediatr Nephrol. 1998;12(2):105\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"356_CR88","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s004670050542","volume":"12","author":"JM Sorof","year":"1998","unstructured":"Sorof JM, Hawkins EP, Brewer ED, Boydstun II, Kale AS, Powell DR. Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Pediatr Nephrol. 1998;12(9):764\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"356_CR89","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1046\/j.1523-1755.1999.00408.x","volume":"55","author":"M Bonilla-Felix","year":"1999","unstructured":"Bonilla-Felix M, Parra C, Dajani T, Ferris M, Swinford RD, Portman RJ, Verani R. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int. 1999;55(5):1885\u201390.","journal-title":"Kidney Int"},{"issue":"3","key":"356_CR90","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","volume":"21","author":"DS Gipson","year":"2006","unstructured":"Gipson DS, Chin H, Presler TP, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21(3):344\u20139.","journal-title":"Pediatr Nephrol"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-017-0356-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:33:17Z","timestamp":1692757997000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-017-0356-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,21]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/s13052-017-0356-x","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,21]]},"article-number":"41"}}